谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

High Initial Dosing Regimen With Eptacog Beta (Factor Viia, Recombinant) Is Efficacious In Patients With Hemophilia A Or B With Inhibitors Undergoing Major Surgery: Results From The Persept 3 Clinical Trial

C. Hermans,J. Windyga,M. Escobar, L. Villareal Martinez,D. Quon,O. Alfa Cisse, N. Chambron,A. Al-Sabbagh,D. Bonzo, I. S. Mitchell,J. Mahlangu

HAEMOPHILIA（2021）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要